We import essential medicines to address shortages and meet market demands, strictly adhering to MOH and Iran FDA regulations. Our portfolio spans critical therapeutic areas:
- Metabolism & Endocrinology
- Infectious Diseases
- Oncology
- Immunology
- Critical Care
At MOH’s request, we introduce innovative, unregistered drugs like Jakavi, Cabometyx, Zejula, and Blincyto, ensuring patients access cutting-edge treatments. Expanding into manufacturing, we’re partnering with global and local suppliers to produce high-quality drugs in Endocrinology, Oncology, and Critical Care.
Contact us to explore our pharmaceutical solutions.